Evidence map›Paper›PMID 42192481›Full record

ArticleJournal of ovarian research2026

Distinct pregnancy challenges in PCOS women undergoing IVF/ICSI with singleton and twin births: a propensity-matched analysis.

Zhekun Zhao, Minyue Tang, Shan Wan, Sisi Wang, Bingbin Xu, Yimin Zhu

Abstract read
In one paragraph

Article in Journal of ovarian research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zhekun Zhao *Department of Reproductive Endocrinology, Women's Hospital, Zhejiang University school of Medicine, Hangzhou, Zhejiang, 310006, China.
Minyue Tang *Department of Reproductive Endocrinology, Women's Hospital, Zhejiang University school of Medicine, Hangzhou, Zhejiang, 310006, China.
Shan WanDepartment of Reproductive Endocrinology, Women's Hospital, Zhejiang University school of Medicine, Hangzhou, Zhejiang, 310006, China.
Sisi WangDepartment of Reproductive Endocrinology, Women's Hospital, Zhejiang University school of Medicine, Hangzhou, Zhejiang, 310006, China.
Bingbin XuDepartment of Reproductive Endocrinology, Women's Hospital, Zhejiang University school of Medicine, Hangzhou, Zhejiang, 310006, China.
Yimin ZhuDepartment of Reproductive Endocrinology, Women's Hospital, Zhejiang University school of Medicine, Hangzhou, Zhejiang, 310006, China. zhuyim@zju.edu.cn.

Funding

Key Research and Development Program of Zhejiang Province 2025C02116
6 · The paper itself

Abstract

backgroundPolycystic ovary syndrome (PCOS) has been associated with adverse pregnancy outcomes; however, current literature presents inconsistent findings, probably due to varying feotal numbers included in previous research. This study sought to evaluate pregnancy outcomes in women with PCOS undergoing assisted reproductive technology (ART), with a specific focus on differentiating between singleton and twin births.

methodsThis cohort study included women who underwent in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) and maintained pregnancies beyond 20 weeks of gestation. Participants with PCOS or tubal factors were matched using 1:2 propensity score matching (PSM) separately within singleton and twin birth cohorts. Maternal and neonatal outcomes were collected from 95 hospitals and analysed using conditional logistic regression with cluster-robust standard errors (CRSEs) at hospital levels. Mediation analysis was further conducted to identify pathways between PCOS and several adverse outcomes.

resultsFrom 1 June 2017 to 31 May 2022, 696 PCOS women and 1392 controls with singleton births, as well as 201 PCOS women and 402 controls with twin births, were matched for final analysis. In singleton birth cohort, PCOS women were associated with hypertensive diseases of pregnancy [HDP; crude odds ratio (OR) = 1.91, P adjusted for multiple comparisons < 0.001, the same below], pre-eclampsia (PE; OR = 1.67, P < 0.01), and cervical incompetence (CIC; OR = 3.84, P < 0.001). In twin birth cohort, PCOS women had increased odds of gestational diabetes mellitus (GDM; OR = 2.23, P < 0.001) and very preterm birth (VPTB; OR = 2.08, P < 0.01), compared to their counterparts. No significant between-group differences were observed for preterm premature rupture of membranes (PPROM). The findings were consistent after regression adjustments, multiple comparison correction, subgroup analyses, and sensitivity analyses. Subsequent mediation analysis highlighted preconception BMI and insulin resistance (IR) as key mediators to PCOS-related HDP and PE for women with singleton births. Further exploratory analysis indicated several preconception prognostic factors of adverse pregnancy outcomes in PCOS, especially metabolic indicators.

conclusionsIn this study, women with PCOS who had singleton births demonstrated a higher incidence of hypertension and CIC compared to those with tubal factors. Among women with twin births, increased risks of GDM and VPTB were noted in addition to the inherent risks of twin gestation. Our findings contribute to the body of evidence regarding the differential pregnancy outcomes based on foetal number in PCOS women undergoing ART, highlighting the necessity of individual reproductive and obstetric management in clinical practice.

Indexed as

Fertilization in VitroPolycystic Ovary SyndromePregnancy, TwinSperm Injections, IntracytoplasmicAdultFemaleHumansPregnancyPregnancy OutcomePropensity ScoreDiabetes mellitusHypertensionIntracytoplasmic sperm injectionIn vitro fertilizationPolycystic ovary syndromePregnancy outcomesPreterm birthTwins

Identifiers

PMID42192481
PMCPMC13397808

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.